Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...

Полное описание

Библиографические подробности
Главный автор:	Hobbs, F
Формат:	Journal article
Язык:	English
Опубликовано:	2003

Схожие документы

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
по: article Editorial
Опубликовано: (2020-09-01)

Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
по: Hobbs, R, и др.
Опубликовано: (2005)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
по: Alberto J Lorenzatti, и др.
Опубликовано: (2020-02-01)

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
по: Mach, F, и др.
Опубликовано: (2019)

Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
по: Meor Anuar Shuhaili, Meor Fairuz Rizal, и др.
Опубликовано: (2018)

Seasonal variation lipid levels in the patients with dyslipidaemia
по: I V Radysh, и др.
Опубликовано: (2009-12-01)

Cardiovascular risk management in primary care.
по: Hobbs, F
Опубликовано: (2002)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
по: Francois Mach, и др.
Опубликовано: (2020-06-01)

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
по: Sung-Bum Lee, и др.
Опубликовано: (2022-07-01)

Current insights on dyslipidaemia management for prevention of atherosclerotic cardiovascular disease: a malaysian perspective
по: Wan Ahmad, Wan Azman, и др.
Опубликовано: (2023)

Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
по: M R Essop, и др.
Опубликовано: (2023-11-01)

Managing dyslipidaemia in patients with chronic kidney disease
по: Ashwani Mehta
Опубликовано: (2024-03-01)

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
по: Alicja E. Grzegorzewska, и др.
Опубликовано: (2021-03-01)

Serum zinc levels in diabetic patients with and without dyslipidaemia and cardiovascular diseases
по: Lakmal Jayaweera, и др.
Опубликовано: (2020-08-01)

Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension
по: Saxena S, и др.
Опубликовано: (2015-07-01)

New concepts in the management of dyslipidaemia
по: Baris Gencer, и др.
Опубликовано: (2016-11-01)

Managing dyslipidaemia in young adults
по: Jamshed J. Dalal, и др.
Опубликовано: (2024-03-01)

Role of statins in the management of dyslipidaemia
по: Saumitra Ray
Опубликовано: (2024-03-01)

The changing paradigm of dyslipidaemia management
по: Ruvan Ekanayaka
Опубликовано: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
по: Iciar Martín-Timón, и др.
Опубликовано: (2018-11-01)

The scale of heart failure: diagnosis and management issues for primary care.
по: Hobbs, F
Опубликовано: (1999)

Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.
по: Hobbs, F
Опубликовано: (2004)

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
по: Maciej Banach, и др.
Опубликовано: (2022-09-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
по: Alberto Zambon
Опубликовано: (2020-04-01)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
по: Di Liu, и др.
Опубликовано: (2018-08-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
по: Anandita Agarwala, и др.
Опубликовано: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
по: Giuseppe Danilo Norata
Опубликовано: (2012-01-01)

Secondary dyslipidaemia
по: D.J. Blom
Опубликовано: (2011-07-01)

Diabetic dyslipidaemia
по: Subashini C. Thambiah, и др.
Опубликовано: (2021-08-01)

Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
по: Martina Meszaros, и др.
Опубликовано: (2022-10-01)

Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.
по: Erhardt, L, и др.
Опубликовано: (2008)

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study
по: In Wong, и др.
Опубликовано: (2020-01-01)

Optimisation of lipids for prevention of cardiovascular disease in a primary care
по: Smita Bakhai, и др.
Опубликовано: (2018-07-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
по: Tiny Nair
Опубликовано: (2024-03-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
по: Alberico L. Catapano, и др.
Опубликовано: (2017-06-01)

Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
по: Dalia Luksiene, и др.
Опубликовано: (2014-01-01)

Dyslipidaemia and inflammatory markers as the risk predictors for cardiovascular disease in newly diagnosed premenopausal hypothyroid women
по: Balamurugan Vaideki, и др.
Опубликовано: (2023-01-01)

Dyslipidaemia in endocrine disorders
по: Kalyani Sridharan, и др.
Опубликовано: (2024-03-01)

Treatment of Dyslipidaemia in Children
по: Riccardo Fiorentino, и др.
Опубликовано: (2021-08-01)

Dyslipidaemia in Sri Lanka
по: Anne Thushara Matthias, и др.
Опубликовано: (2022-01-01)